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Abstract  
Objectives  
This study is to investigate the angiogenesis and vasculogenesis at the first week of reperfused acute 
myocardial infarction (AMI). 
Methods  
16 of mini-swines (20 to 30 Kg) were randomly assigned to the sham-operated group and the AMI 
group. The acute myocardial infarction and reperfusion model was created and the pig tail catheter was 
performed to monitor hemodynamics before left anterior descending coronary artery (LAD) occlusion, 
90 min of LAD occlusion and 120 min of LAD reperfusion. Pathologic myocardial tissue was collected 
at 7-day of LAD reperfusion and further assessed by immunochemistry, dual immunochemistry, in-situ 
hybridization, real-time quantitative polymerase chain reaction and western blot.  
Results  
The infarcted area had higher FLK1 mRNA expression than sham-operated area and the normal area 
(all P<0.05), and the infarcted and marginal areas showed higher CD146 protein expression than the 
sham-operated area (all P<0.05), but the microvessel density (CD31 positive expression of 
microvessels/HP) was not significantly different between the infarcted area and the sham-operated area 
(8.92±3.05 vs 6.43±1.54) at 7-day of reperfused acute myocardial infarction (P>0.05).  
Conclusions  
FLK1 and CD146 expression significantly increase in the infarcted and marginal areas, and the 
microvessel density is not significantly different between the infarcted area and the sham-operated area, 
suggesting that angiogenesis and vasculogenesis in the infarcted area appear to high frequency of 
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increase in 7-day of reperfused myocardial infarction.  
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Introduction  
Today salvaging the jeopardized myocardium is one of the most important clinical goals in acute 
myocardial infarction. However, after infarction, a repair process is initiated that strongly depends on 
vascular status. Rapid angiogenesis and residual vascular potency are important to the re-establishment of 
coronary collateral circulation and to the improvement of blood supply to the infarction zone and its 
periphery. FLK1, the tyrosine kinase receptor for vascular endothelial growth factor, is a marker for lateral 
plate mesoderm and the earliest differentiation marker for endothelial cells and blood cells1 and FLK1 has 
been generally regarded as the major regulator of vasculogenesis (the recruitment of bone marrow-derived 
progenitors for endothelial cells )2 and angiogenesis (the sprouting of preexisting vessels).3,4  
Noticeably CD146 (Mel-CAM) is a ~118 kd member of the immunoglobulin superfamily of cell 
adhesion molecules5 that was first recognized as a melanoma tumor progression antigen.6-8 It is believed to 
be important for tumor cell–endothelium interaction.9,10 CD146 joins VE-cadherin and CD31 (PECAM-1) 
as a molecule that mediates homotypic endothelial cell adhesion. CD146 has both structural functions and 
signaling functions important for endothelial monolayer integrity.11
On the other hand, CD31 is single strand glycoprotein distributed in cell membrane surface of 
endothelial cells, circulating platelets, monocytes, neutrophils, certain lymphocyte subsets, and 
megakaryocytic cell lines,12,13 which used as endothelial marker in angiogenesis and vascularization 
investigation.14-16
To update, there is relatively little information regarding FLK1 and CD31, especially CD146 pattern of 
expression in case of reperfused acute myocardial infarction, thus we conducted a histopathology natural 
history study to investigate microvessel angiogenesis and vasculogenesis at 7-day of reperfused acute 
myocardium infarction. 
 
Methods  
 
Animal preparation 
The animals and protocols used in the study were approved by the Institutional Animal Care and Use 
Committee. The mini-swines (20 to 30 Kg) were fasted overnight, sedated with 10 mg/kg of azaperone 
intramuscularly, anesthetized with 10 mg/kg of thiopental intravenously and ventilated with a respirator 
(Siemens elema sv 900, olna, Swede). Tidal volumes of 12 ml/kg with a set respiratory rate of 16 breaths 
per minute were used at first. Arterial PH, PaCO2, and PaO2 were monitored throughout the protocol by a 
blood gas analyzer (AGM-123-23, Finland) and maintained in a normal physiological range by adjusting 
the respiratory rate and/or tidal volume. Anesthesia was maintained with a continuous infusion of 
thiopental. A left lateral thoracotomy was performed, and the heart was suspended in a pericardial cradle. 
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The middle and distal portion of the left anterior descending coronary artery (LAD) was excised from 
surrounding tissue and was encircled by a suture. The two ends of the suture were threaded through a 
length of plastic tubing, forming a snare, which could be tightened to occlude the coronary artery. The right 
femoral artery were cannulated by 6 Fr pigtail guiding catheter for haemodynamic monitoring. 
Sixteen animals were randomly assigned to eight sham-operated group and eight reperfused acute 
myocardial infarction group. The AMI and reperfusion model was created with 90 min of LAD occlusion 
followed by 7-day reperfusion. In the sham-operated animals, the LAD was only encircled by a suture, but 
not occluded. After the operation, the animals were sent to the observed room and were raised for 7 days, 
then were executed and we collected the relevant heart tissue. 
 
Haemodynamic function 
LAD occlusion was verified by ST segment elevation on the electrocardiogram. At baseline, at the end of 
90 min of LAD occlusion and at 120 min of reperfusion, we measured heart rate (HR), left ventricular 
systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), the maximum change rate of left 
ventricular pressure rise and fall (±dp/dtmax). 
 
Histopathological evaluation 
After the completion of the experimental protocol, the swine was executed, the hearts were cut transversely 
and serially from the apex to the base (Figure 1). A slice obtained from the midpoint between the base and 
apex, which contained the greatest focus of myocardial infarction, was then cut from the myocardium in the 
three regions (the infarcted area, the marginal area and the normal area) in AMI group and healthy heart 
tissue (the sham-operated area) in the sham-operated group, washed thoroughly with saline and snap-frozen 
in liquid nitrogen or were fixed in 10% phosphate-buffered formalin (pH 7.35) and embedded in paraffin, 
cut into 4-µm sections, and affixed to glass slides for immunohistochemistry and in situ hybridization. 
(During all procedures, DEPC water and precaution against RNases were taken.) 
 
In situ hybridization  
First-strand cDNA synthesis was performed by the technicians in Beijing augct biotechnology company 
(Beijing, China ). FLK1 cDNA sequence: AGATTACAGATCTCCATTTATTGCTTCTGTTAGTGACCA 
GCATGGAGTTGTGTACATCAC. After firststrand synthesis, cDNA was generated by PCR amplification 
with 10 pmol of specific primers for 30 cycles of amplification (94°C 1 s, 62°C 1 s, 72°C 1 s). cDNA probe 
labeling with digoxigenin-UTP by in vitro transcription with T7 RNA polymerase was performed as the 
manufacturer’s instructions (DIG RNA labeling kit, SP6/T7, Boehringer Mannheim). Heart tissue was 
performed on 4-mm paraffin-embedded material sections using a nonradioactive in situ hybridization 
technique (Boehringer Mannheim). Using DEPC-treated equipment and solutions, paraffin-embedded 
specimens underwent sectioning, rehydration, and incubation in a prewarmed 5 ug/ml proteinase K solution. 
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Slides were then reimmersed in 4% PFA, treated with a 0.25% acetic anhydride, and dehydrated. Sections 
were exposed to a hybridization solution containing 50% formamide, 10% dextran sulfate, 1 mg/ml tRNA, 
1×Denhardt’s solution, 4×SSC, 50 mM Tris, and 5 mM EDTA that contained 20 ng/ul of DIG-labeled 
cDNA probe at 42°C overnight (10~12 hours). Slides were washed at 37°C in 2×SSC, 0.5×SSC, and 
0.2×SSC twice for 15 min. After being rinsed with 0.2×SSC, DIG nucleic acid detection was accomplished 
using the Boehringer Mannheim. Slides underwent blocking in a 1% block reagent for 37℃ 30 min. 
Following blocking, slides were incubated with rabbit anti-DIG conjugate at 37°C 60 min, rinsed four times 
with 0.05 mmol/l PBS for 5 min each time, and similarly incubated goat anti-rabbit-AP IgG at 37°C 60 min, 
rinsed four times with 0.05 mmol/l PBS for 5 min each time, and then incubated with a dilute NBT/BCIP 
solution for 30min at 37℃. Slides were counterstained with a 0.1% nuclear fast red solution for 5 min, 
rinsed in water, air dried, and mounted. Hybridization without probe was performed as negative control and 
always showed no signals. All sections were examined and photographed under light microscopy. 
Four hot spots of microvessel angiogenesis and vasculogenesis were searched in the stained sections 
under low power of light microscope (10×10), then computed the percentage of microvessel endothelial 
cells coated positive FLK1 mRNA expression divided by total microvessel endothelial cells under high 
power field (10×40) by the Leica Application Suite V2.3.4 R2 software (Leica Microsystems Ltd, 
Switzerland). 
Immunohistochemistry  
We randomly drew three samples from each group and employed primary antibody a mouse anti-human 
FLK1 antibody, secondary antibody polyclonal rabbit anti-mouse IgG (both from SANTA CRUZ 
BIOTECHNOLOGY, INC, U.S.A) for immunohistochemistry stain. Tissues were deparaffinized and 
underwent peroxide quenching. Using a histostain kit from Zhongshan Goldenbridge biotechnology Co 
(Beijing, China), after blocking, the sections were exposed to the primary antibody overnight at 4°C. 
Sections were then incubated with secondary biotinylated antibody as per the manufacturer’s protocol. 
Horseradish peroxidase activity was visualized with a diaminobenzidine substrate and the sections were 
faintly counterstained with hematoxylin, and then observed under light microscope at 100× and 400× 
magnification. 
Dual Immunohistochemistry  
Dual immunohistochemistry was performed using peroxidase-based staining for smooth muscle actin 
simultaneously stained by alkaline phosphatase-based staining for CD31 developed with the polymer dual 
immunohistochemistry kit (Zhongshan Goldenbridge biotechnology Co, Beijing, China). Briefly, sections 
were pretreated with 3% hydrogen peroxide to inhibit endogenous peroxidase activity and incubated with 
2% horse serum to block nonspecific protein binding. Subsequently, they were incubated with the primary 
antibody mouse anti-human α-smooth muscle actin and rabbit anti-human CD31(both from SANTA CRUZ 
BIOTECHNOLOGY, INC, U.S.A) for 10~12 hours at 4℃. After rinsing with PBS, the slides were 
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incubated for 30 min with the secondary antibody goat anti-mouse horseradish peroxidase IgG conjecture 
and goat anti-rabbit alkaline phosphatase IgG conjecture (both from Zhongshan Goldenbridge 
biotechnology Co, Beijing, China). The slides were rinsed with PBS and incubated for 30 min in ABC 
reagent.17 Peroxidase activity was detected using diaminobenzidine with nickel (Vector). Slides were 
counterstained with hematoxylin. Sections incubated with PBS instead of primary antibody were used as 
negative controls. Angiogenesis endothelial cells marker CD31 ware stained into red color, and α-smooth 
muscle actin in vessel wall was stained into brown-yellow color. According to Weidner criterion:18 single 
endothelial cell or endothelial cells’ cluster marked with red color was defined as a microvessel, and 
excluded small artery with thick vascular smooth muscle and the luminal diameter beyond total 8 of red 
cells’ diameters. Microvessel density (CD31 positive expression of microvessels/HP) measurement: firstly, 
3 hot spots of angiogenesis and vasculogenesis were searched in the stained sections under low power of 
light microscope (10×10), then compute average of microvessels coated with CD31 positive endothelial 
cells under 4 of high power field (HP:10×40) by the Leica Application Suite V2.3.4 R2 software (Leica 
Microsystems Ltd, Switzerland).  
 
Tissue preparation and RNA isolation 
We randomly sampled 6 of specimen from each group (the sham-operated area, the infarcted area, the 
marginal area and the normal area) for Real-time Quantitative Polymerase Chain Reaction (RQ-PCR). A 
piece of frozen tissue (0.1– 0.5 g) was grinded in liquid nitrogen. Total RNA was prepared immediately 
with Trizol reagent, according to the manufacturer’s protocol using Trizol (Invitrogen Life Technologies, 
Carslbad, CA). Briefly, a piece of frozen tissue (50~100mg) were homogenized with 1~2 ml of Trizol, after 
which 400 ul of chloroform was added and the mixture was shaken vigorously, followed by centrifugation 
at 12 000 rpm for 15 min. Total RNA was precipitated by isopropyl alcohol and then dissolved with 30~35 
ul of RNase-free water. 
 
Real-time Quantitative Polymerase Chain Reaction (RQ-PCR) 
A RQ-PCR method was used for detection of FLK1 mRNA expression. The RT-PCR kit (Invitrogen Life 
Technologies Co, U.S.A) and the ABI PRISM 7700 Sequence Detector (ABI Co, U.S.A) were used 
according to the manufacturer’s protocol. β-specific mRNA was used for standardization. Each sample was 
detected in thrice. Standard curves had a correlation coefficient of > 0.998. The specific RNA was 
determined in the different heart tissue (the sham-operated area, the infarcted area, the marginal area and 
the normal area) from 1ug of total RNA to be reversed and transcribed into cDNA using a SuperScriptw 
first-strand synthesis system for RT-PCR (Invitrogen Life Technologies Co, U.S.A). The first strand cDNA 
was amplified using Taq polymerase (Takara, Shiga, Japan). Sybr Green I (10×) was used for label 
(Invitrogen Life Technologies Co, U.S.A). The oligonucleotide primer sequences used for the PCR 
reactions were indicated as following. The presence of corresponding PCR products was verified by 
electrophoresis on a 2% agarose gel in 1x Tris–acetate– EDTA buffer. 
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 PCR reagent formulation: 
          cDNA                     2ul 
          dNTPs (10mM)              0.5ul 
          10×PCR buffer              2.5ul 
          primer f (20pmol/ul)          0.25ul 
          primer r (20pmol/ul)          0.25ul 
          Taq DNA polymerase mixture   0.2ul 
   Sybr Green I (10×)           1ul 
          ddH2O                     (add ddH2O to total volume 25ul) 
        
RQ-PCR condition:  
(1) β-actin:  
Cycle time: 90 Seconds;  
94℃ predenaturalization for 2 min;  
94℃ denaturalization for 150 sec;  
72℃ annealing and extension for 30/30 sec;  
CT: 35 cycles;  
Primer F 5’→3’ ATCATGTTTGAGACCTTC AACA;  
Primer R 5’→3’ CATCTCTTGCTCGAAGTCCA;  
PCR production: 318 bp.  
(2) FLK1:  
Cycle time: 60 Seconds;  
94℃ predenaturalization for 2 min;  
94℃ denaturalization for 150 sec;  
72℃ annealing and extension for 30/30 sec;  
CT: 35 cycles;  
Primer F 5’→3’ TGATCGGAA ATGACACTGGA;  
Primer R 5’→3’ TTCTGGATACCTCGCACAAA;  
PCR production: 224 bp.
 
Western blot analysis for CD146 in heart tissue 
The heart biopsy specimens was washed by physiological saline and frozen at −70 °C until use. Protein 
concentration was determined by the method of Bradford.19 100 μg of total protein solubilized for 10 min at 
100 °C was loaded per lane onto a 10% SDSPAGE gel. Electrophoresis was performed for 40~60 min at 
120 v. Proteins were transferred onto immobilon-P transfer membrane (Millipore, Bedford, MA, U.S.A.) 
for 1.5~3 h at 0.8 mA/cm2 in a 20% methanol containing cathodes buffer. The membrane was washed in 
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PBST (0.1% Tween 20, 100 mM Tris–HCL, 150 mM NaCl, pH 7.5), blocked for 1 h in 5% nonfat 
milk-TBST (pH 7.2 Tris-buffered saline containing 0.05% Tween 20) and incubated with 1:300 dilution of 
goat anti-human polyclonal antibodies CD146 (from Santa Cruz Biotechnology Inc, U.S.A). After being 
washed, the membrane was incubated with a 1:5000 dilution of the rabbit anti-goat secondary antibody 
(Sigma-Aldrich Co, U.S.A) for 30 min at room temperature. To express the tested proteins relative to actin, 
membranes were reblotted with anti-actin antibody, and relative intensities of protein and β-actin calculated. 
β-actin protein expression served as an internal control. For quantification, Western blot gels were scanned 
and bands quantified by integrating intensity and area using a commercial computer program 
(AlphalmagerTM IS-3400 V. 4.0.1, Alpha Innotech, U.S.A ).  
Statistical methods 
Data was evaluated for normality of distribution. Comparisons of data among all stages were performed 
with one-way ANOVA followed by the Newman-Keuls multiple comparison test. The nonparametric 
Mann-Whitney U test was used in skew data. The proportion was analyzed by Chi-square test. All 
statistical analyses were performed with SPSS for windows (version 10.0, Chicago). A value of P<0.05 
(2-sided) was considered statistically significant.  
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Result  
Comparied with the sham-operated group, the AMI group had higher dp/dtmax (3048.57±564.37 vs 2335.88 
±623.48, P=0.038) in left ventricle before the LAD was occluded (Table 1), but not significant difference 
between the two groups in other variables including weight, male (%), heart rate, systolic and diastolic 
aortic pressure, LVSP, LVEDP and -dp/dtmax.  
In situ hybridization detection, the infarcted and marginal areas had higher the positive rate of FLK1 
mRNA expression compared with the normal area and the sham-operated area (P<0.05), and so were the 
infarcted area vs. the marginal area (P<0.05) (Figure 2). 
In RQ-PCR analysis, the infarcted area showed significantly higher the FLK1 mRNA expression 
compared with the normal area and the sham-operated area (P<0.05) (Figure 3) 
According to immunohistochemical staining, the FLK1 protein expression was found in the infarcted 
area but not in the marginal area, the normal area and the sham-operated area (Figure 4).  
In Western blot analysis, the infarcted and marginal areas had higher the CD146 protein expression 
compared with the normal area and the sham-operated area (P<0.05) (Figure 5). 
Using dual immunohistochemical staining, we found that the microvessel density (CD31 positive 
expression of microvessels/HP) between the infarcted area and the sham-operated area was not statistically 
significant (8.92±3.05 vs 6.43±1.54) at 7-day of reperfused acute myocardial infarction (P>0.05) (Figure 
6).  
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Discussion 
In 7-day of reperfused acute myocardial infarction, the present study found (1) the infarcted area had higher 
FLK1 mRNA expression than sham-operated area and the normal area; (2) the infarcted area also showed 
higher CD146 protein expression than the sham-operated area; (3) the microvessel density was not 
significantly different between the infarcted area and the sham-operated area, suggesting angiogenesis and 
vasculogenesis in the infarcted area appear to high frequency of increase in the infarcted area. 
Vessel growth and maturation are critical for scar formation and cardiac repair. This process represents 
an important therapeutic target in our efforts to improve post-infarction cardiac recovery.20,21 Infarct 
microvessels undergo phenotypic changes and, after an initial phase of plasticity associated with intense 
angiogenic activity to meet the metabolic needs of the cellular scar, pericyte recruitment may mark the 
creation of a more mature vasculature.22
Angiogenic endothelial cells demonstrate phenotypic characteristics distinctly different from those of 
resting quiescent endothelial cells. Sprouting neovessels have been shown to express the integrins αvβ3 23,24 
and αvβ5,25 the cell surface glycoprotein Thy-1,26 and the VEGF receptor FLK1/kDR,27 whereas 
proliferating endothelial cells demonstrate increased expression of adhesion molecules such as E-selectin.28
The knockout studies show that homozygous disruption of FLK1 gene leads to early embryonic death 
due to a failure of vasculogenesis, whereas homozygous Flt1 disruption allows normal vascular endothelial 
differentiation and development but leads to a failure to assemble normal vascular channels.29,30  
Ischemia induced VEGF and its receptors (FLK1 and Flt1) upregulation, and increase angiogenesis and 
vasculogenesis in ischemic myocardium.31 In situ hybridization, only endothelial cells were expressing 
these receptors. Another unexpected observation was the finding that while Flt1 was expressed in 
endothelium of both large and small vessels, FLK1 expression was restricted to small (<l00 mm in diameter) 
vessels, and the increased VEGF, FLK1 and Flt1 mRNA expression in the left ventricular myocardium as 
early as 1 h after LAD ligation in the rat, furthermore, by 7 days and as late as 6 wk, elevated expression of 
mRNA of FLK1 and Flt1 was confined to the infarct zone.32 Similarly we also found that there was 
increased positive rate of FLK1 mRNA expression by the viable endothelial cells in the infarcted area at 
7-day of LAD reperfusion, and only FLK1 protein expression was found in the infarcted area by 
immunohistochemistry stain. 
CD146 is a transmembrane glycoprotein constitutively expressed on endothelial cells,33,34 with a 
potential role in cell adhesion and in the rearrangement of the actin cytoskeleton.35 Infarct microvessels 
showed CD146 immunoreactivity in all stages of healing. Although biologic functions have been ascribed 
to CD146 expression on various cell types, very little is known about the biologic role of CD146 on 
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endothelial cells. Endothelial CD146 is found to support homotypic cell to cell adhesions that are important 
in maintaining blood vessel integrity and in controlling intercellular permeability.36,37 The ability of 
endothelial cells to form heterotypic CD146-dependent adhesions may be important in transendothelial 
migration or even hemangioblast differentiation.11
Late studies found that CD146 showed specific overexpression in angiogenesis and vasculogenesis 
process,38 for example, the infarct endothelial cells in the early phase of healing showed intense staining for 
CD31 and CD146,22 which was consistent with our findings that the infarcted area showed higher CD146 
protein expression compared with the sham-operated area (P<0.05). 
Platelet/endothelial cell adhesion molecule-1 (CD31) is a 130-kD member of the immunoglobulin gene 
superfamily whose expression is restricted exclusively to certain cells of the vasculature.39,40 On endothelial 
cells, CD31 is expressed constitutively at 1x106 molecules per cell, making CD31 the most highly 
expressed adhesion molecule on the endothelial cell surface.12  
Healing MIs contain a large number of capillaries in the early stages of healing.41 Scar maturation was 
associated with the increasing presence of pericyte-coated vessels in the infarcted region. In the early stages 
of healing (7 days of reperfusion), significant numbers of microvessels without an α-smooth muscle 
actin-positive pericyte coat were noted.22 Similarly our study suggested that the microvessel density (CD31 
positive expression of microvessels/HP) was slightly higher in the infarcted area compared with the 
sham-operated area (8.92±3.05 vs 6.43±1.54, P>0.05), thus we speculate that angiogenesis and 
vasculogenesis in the infarcted area appear to high frequency of increase in 7-day of reperfused myocardial 
infarction. 
Limitation (1) we did not elucidate the mechanism of microvessel angiogenesis and vasculogenesis 
influence on left ventricle remodeling in the salvaged myocardial tissue at 7-day of reperfused myocardial 
infarction. (2) angiogenesis and vasculogenesis are a very complex process, and methods are available for 
demonstrating the wide range of gene products involved at all its stages. Further examinations of VEGF, 
Flt1 and circulating endothelial progenitor cells are warranted.  
Conclusion 
FLK1 and CD146 expression significantly increase in the infarcted and marginal areas, and the microvessel 
density is not significantly different between the infarcted area and the sham-operated area, suggesting that 
angiogenesis and vasculogenesis in the infarcted area appear to high frequency of increase in 7-day of 
reperfused myocardial infarction. 
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Table 1. General and hemodynamics characteristics in the reperfused myocardial infarction model. 
 Sham-operated group  
(N = 8) 
AMI group  
(N = 8) 
P value  
 
Weight (kg) 19.39±2.75 22.04±2.35 0.065 
Gender (male, %) 42.9 50.0 0.782 
Heart Rate (beats/min) 
Baseline   
 
Note: Note: data was described as mean±SD or proportion. LVSP, left ventricular systolic pressure; LVEDP, left 
ventricular end-diastolic pressure; ±dp/dtmax, the maximum change rate of left ventricular pressure rise and fall.  
   Ischaemic 90 min 
   Reperfusion 120 min 
 
113.63±29.14 
112.14±22.70 
109.00±31.86 
 
108.88±23.46 
117.71±27.34 
110.00±27.85 
 
0.725 
0.686 
0.948 
Systolic aortic pressure (mm Hg)  
Baseline   
   Ischaemic 90 min 
   Reperfusion 120 min 
 
108.00±18.99 
103.09±19.13 
98.45±24.83 
 
110.94±31.05 
99.59±18.52 
92.75±30.38 
 
0.822 
0.734 
0.707 
Diastolic aortic pressure (mm Hg)  
Baseline   
   Ischaemic 90 min 
   Reperfusion 120 min 
 
75.59±26.73 
76.36±16.84 
73.74±27.04 
 
82.05±24.79 
76.70±13.19 
65.35±19.96 
 
0.624 
0.967 
0.521 
LVSP (mm Hg) 
Baseline   
   Reperfusion 120 min 
 
111.62±19.15 
102.38±21.55 
 
112.14±27.44 
87.76±25.70 
 
0.966 
0.258 
LVEDP (mm Hg) 
Baseline   
   Reperfusion 120 min 
 
1.14±5.88 
-0.21±6.60 
 
-1.96±5.97 
-0.54±5.46 
 
0.330 
0.918 
+dp/dtmax (mm Hg/s) 
Baseline   
Reperfusion 120 min 
 
2335.88±623.48 
2036.57±635.09 
 
3048.57±564.37 
1883.75±606.02 
 
0.038 
0.642 
-dp/dtmax (mm Hg/s) 
Baseline   
Reperfusion 120 min 
 
-1528.88±535.42 
-1548.43±655.85 
 
-1591.43±274.19 
-1262.50±696.29 
 
0.785 
0.430 
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A                                        B 
         
C                                        D 
         
E                                        F 
         
Figure 1. The myocardial biopsy specimens at 7-day of reperfused acute myocardium infarction.  
Because the heart tissue specimen was taken at 7-day of reperfused acute myocardium infarction, and the infarcted 
myocardium (red arrow) was clearly distinguished from the non-infarcted myocardial tissue at naked eye view, thus the 
infarcted core was defined as the infarcted area; the periph-myocardium of the infarcted area including the infarcted 
myocardial tissue less than 10 percent of total crosssectional myocardial area was considered as the marginal 
myocardium area; the normal myocardium area indicated remote myocardium which was far away from the infarcted 
and marginal myocardium area and irrelevant to the distribution of occluded coronary artery blood supply. A: the heart 
biopsy specimens overview; B: the slices of heart biopsy specimens; C: the myocardium of infarcted area; D: the 
myocardium of marginal infarcted area; E: the myocardium of normal area; F: the myocardium of sham-operated area. 
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Figure 3. FLK1 mRNA expression in RQ-PCR 
 
   A and B were presented as 24 samples of quantitative fluorescence curve of β－actin and FLK1 mRNA expression 
in PCR cycle respectively, the y axis indicated the fluorescence signal recorded in each amplification cycle, as plotted 
along the x axis showed the cycle number of copies of cDNA per reaction. C and D indicated the standard curve of β－
actin and FLK1 respectively, the plot shows an amplification of a limiting-dilution series of standard cDNA in vitro. 
The standard curve graph presented showing the relation between the logarithmic transformation of concentration in a 
limiting-dilution series of standard samples (on the x axis) and Ct value followed PCR cycle in the respective samples 
(on the y axis). The standard curve allowed quantification of cDNA in the included samples. FLK1 mRNA expression 
in the sham-operated area (n=6), the infarcted area (n=6), the marginal area (n=6) and the normal area (n=6) by 
RQ-PCR analysis. β-actin was internal control, and results (n=6) were presented as means ± s.e.m. *P < 0.05 vs. the 
sham area; + P < 0.05 vs. the normal area; # P< 0.05 vs. the marginal area. 
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A: the sham-operated area (light microscope,10x10); B: the sham-operated area (light microscope,10x40); C: the infarcted area (light microscope,10x10); D: the 
infarcted area (light microscope,10x40); E: the marginal area (light microscope,10x10); F: the marginal area (light microscope,10x40); G: the normal area (light 
microscope,10x10); H: the normal area (light microscope,10x40). FLK1 protein expression was stained into brown color (red arrow). 
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Figure 5. CD146 protein expression in heart tissue of the sham-operated group and the AMI group at 7-day 
of reperfused myocardial infarction.  
 
CD146 protein expression in the sham-operated area (n=8), the infarcted area (n=8), the marginal area (n=8) and the 
normal area (n=8) by Western blot analysis. β-actin was internal control, and results (n=8) were presented as means ± 
s.e.m. *P < 0.05 vs. the sham area; + P < 0.05 vs. the normal area; # P< 0.05 vs. the marginal area.  
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Figure 6. Microvessel density in dual immunohistochemistry stain 
 
It combined alkaline phosphatase-based method for CD31 (red color, blue arrow) and α-smooth muscle actin 
immunohistochemistry with an peroxidase-based staining (brown and yellow color, red arrow). α-smooth muscle actin 
immunoreactivity is predominantly localized in the arteriolar media. A: negative control; B: small arteriole; C: sham-operated 
area; D: the infarcted area. 
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